Live Vaccines: Comprehensive List
The currently available live vaccines include MMR (measles, mumps, rubella), varicella (chickenpox), MMRV (measles-mumps-rubella-varicella), herpes zoster (shingles), rotavirus, live attenuated influenza vaccine (LAIV), yellow fever, oral typhoid (Ty21a), BCG (Bacille Calmette-Guérin), vaccinia (smallpox), and oral poliovirus vaccine (OPV, no longer used in the United States). 1
Live Viral Vaccines
MMR (Measles, Mumps, Rubella): A combination vaccine protecting against three viral diseases, safe for immunocompetent individuals and certain HIV-infected patients with adequate CD4 counts (≥200 cells/mm³ in adults or ≥15% in children) 1, 2
Varicella (Chickenpox): Protects against varicella-zoster virus, can be administered to HIV-infected patients when adults have CD4 count ≥200 cells/mm³ and children aged 1-13 years have CD4 percentage ≥15% 1, 2
MMRV (Measles-Mumps-Rubella-Varicella): Combined vaccine containing all four antigens in a single formulation 1
Herpes Zoster (Shingles): Live attenuated vaccine (Zostavax) for prevention of shingles, distinct from the newer recombinant zoster vaccine (Shingrix) which is inactivated 1
Rotavirus: Oral vaccine for infants to prevent severe rotavirus gastroenteritis, contraindicated in severe combined immunodeficiency 1
Live Attenuated Influenza Vaccine (LAIV): Nasal spray formulation indicated only for healthy people aged 2-49 years, absolutely contraindicated in immunocompromised patients 1, 2
Yellow Fever: Required for travel to endemic areas, contraindicated in severely immunocompromised patients 1
Vaccinia (Smallpox): No longer routinely recommended for the general public 1
Oral Poliovirus Vaccine (OPV): No longer available or recommended in the United States due to risk of vaccine-associated paralytic poliomyelitis 1
Live Bacterial Vaccines
BCG (Bacille Calmette-Guérin): Tuberculosis vaccine, contraindicated in patients with severe T-cell immunodeficiencies and those with IFN-γ-IL-12 pathway defects who have predilection for BCG-induced infection 1
Oral Typhoid (Ty21a Salmonella typhi): Live bacterial vaccine for typhoid fever prevention, contraindicated in severe antibody deficiencies and T-cell defects 1
Critical Safety Considerations for Immunocompromised Patients
Absolute contraindications exist for patients with severe combined immunodeficiency (SCID), complete DiGeorge syndrome, and severe antibody deficiencies (X-linked agammaglobulinemia, common variable immunodeficiency) where all live vaccines must be avoided 1, 2
Patients with phagocytic function disorders (chronic granulomatous disease, leukocyte adhesion defects, myeloperoxidase deficiency) should avoid live bacterial vaccines but can receive live viral vaccines 1
Patients receiving high-dose corticosteroids (≥2 mg/kg/day or ≥20 mg/day prednisone for ≥2 weeks) must wait ≥3 months after discontinuation before receiving live vaccines 2
Household Contact Vaccination
Household members of immunocompromised patients should receive all age-appropriate vaccines including MMR, varicella, rotavirus (for infants), and zoster vaccines to create a protective barrier, with the critical exception that OPV should never be given to household contacts due to transmission risk 1, 2
Both inactivated influenza vaccine (IIV) and LAIV are acceptable for household contacts, as transmission of LAIV virus to immunocompromised individuals is extremely rare 1, 2